Sickle cell disease (SCD) is a group of blood disorders typically inherited from an individual's parents. The most common type is understood as red blood cell anemia (SCA) which leads to an abnormality within the oxygen-carrying protein hemoglobin found in red blood cells. This results in a rigid, sickle-like shape under certain circumstances. Stem cell or bone marrow transplants are the only cure for sickle cell disease, but they're not done very often because of the significant risks involved.

Rising incidence of Sickle cell disease (SCD) has become a key factor in target market growth. Increase in adoption of Gene Therapy has bolstered the development of effective SCD treatment which has further, enhanced the target market growth. Furthermore, improvement in healthcare sector, favorable government policies, increased investment, and growing awareness about hematologic malignancies is expected to exhibit lucrative growth of Sickle Cell Disease Treatment Market.

Sickle Cell Disease Treatment Market was valued at US$ 3.3 Billion in 2024 and is projected to grow at a CAGR of 10.1% to reach US$ 7.8 Billion by 2034.

The report “Sickle Cell Disease Treatment Market, By Treatment Modality  (Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy (Hydroxyurea, Branded Products {Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYNDN (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, and FT-4202})), By End-Users (Hospitals, Specialty Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In December 2021, UCSF Benioff Children’s Hospital Oakland has received largest research trial grant of $17M to launch an innovative clinical trial with four year study by using CRISPR-Cas9 gene-editing technology to cure (SCD) sickle cell disease.
• In June 2021, Ministry of Tribal Affairs organized second National Conclave on Sickle Disease in India on world Sickle Cell on 19^th June, 2021 in partnership with Novartis, FICCI, Apollo Hospitals, Piramal Foundation, GASCDO and NASCO with launch of “Unmukt” project to eliminate SCD (sickle cell disease). The event brought together a group of experts on SCD across India to deliberate on recent advancement in Sickle Cell Disease management with early diagnosis to latest medicine and advancement in treatment of SCD.

Analyst View:

Sickle Cell Disease Treatment market is driven by increasing governments and regulatory bodies support by spending on research and development activities. The availability of high unmet needs, increasing product pipeline for treating sickle cell anemia has created a high demand for the treatment which in turn facilitated the target market growth. Further, evolution of gene therapy and emerging markets such as India, South Africa, Ghana, Brazil, Mexico, and Saudi Arabia is anticipated to boost the demand for Sickle cell anemia treatment market growth over the forecast period.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Sickle Cell Disease Treatment Market, By Treatment Modality  (Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy (Hydroxyurea, Branded Products {Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYNDN (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, and FT-4202})), By End-Users (Hospitals, Specialty Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Sickle Cell Disease Treatment Market was valued at US$ 3.3 Billion in 2024 and is projected to grow at a CAGR of 10.1% to reach US$ 7.8 Billion by 2034.The Sickle Cell Disease Treatment Market is segmented based on Treatment Modality, End-User and Region.

• Based on Treatment Modality, Sickle Cell Disease Treatment Market is segmented into Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy (Hydroxyurea, Branded Products {Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYNDN (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, and FT-4202})).
• Based on End-Users, Sickle Cell Disease Treatment Market is segmented into Hospitals, Specialty Clinics, and Others.
• By Region, the Sickle Cell Disease Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Sickle Cell Disease Treatment Market:

The prominent players operating in the Sickle Cell Disease Treatment Market includes, Baxter, Bluebird Bio, Bristol-Myers Squibb Company, Eli Lilly, Global Blood Therapeutics, Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc., Mast Therapeutics, Novartis AG, Pfizer, Inc., Sanofi and others.  

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com